Sign in

NCT07261956Recruiting

Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Usefulness of Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Source: ClinicalTrials.gov · Last updated 3 Dec 2025

Brief summary (registry, in English)

This research aims to evaluate the usefulness of lung ultrasound (LUS) for detecting and monitoring fluid overload in patients with severe preeclampsia. Severe preeclampsia is a leading cause of maternal death and illness worldwide, often causing fluid buildup that can lead to a serious complication called pulmonary edema, especially after delivery. The study will be a prospective, longitudinal observational study with a diagnostic validation component. It will involve patients with a diagnosis of severe preeclampsia who meet specific inclusion criteria. Each participant will undergo a clinical exam and a lung ultrasound, which will assess eight zones of the lungs. The total number of B-lines-a sign of interstitial edema-will be documented. Data will be collected at three key times: upon admission, in the immediate postpartum period (within 24 hours of delivery), and 7-10 days postpartum. The results from the LUS will be compared to clinical signs like shortness of breath, rapid breathing, crackling sounds in the lungs, and oxygen saturation levels. The expected impact of this research is to provide evidence that LUS is a valuable, non-invasive, and accessible tool for the early detection of pulmonary congestion in patients with severe preeclampsia. This could lead to improved clinical decision-making and a reduction in maternal respiratory complications.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
202 (estimated)
First submitted
24 Aug 2025
Start date
25 Aug 2025
Primary completion date
31 Dec 2025
Lead sponsor
Saint Thomas Hospital, Panama
NCT number
NCT07261956

What you commit to

  • Study type: Interventional
  • Planned participants: 202
  • From 25 Aug 2025 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Chronic lung disease.
  • Known heart disease.

Other

  • Diagnosis of lung edema at admission
  • Body mass index \> 40
  • Need for immediate delivery

Who the study is looking for

  • Preeclampsia with severe features.
  • Gestational age 24 weeks - 41 weeks.

Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Saint Thomas Hospital
Coordinator of this site? Confirm its status
Panama CityPanamaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.